SCL Science Inc. (KOSDAQ:246960)
South Korea · Delayed Price · Currency is KRW 2,115.00
+5.00 (0.24%)
At close: Feb 20, 2026
SCL Science Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 16,319 | 4,737 | 1,322 | 369.78 | 507.29 | 596.19 |
Other Revenue | - | - | -0 | -0 | - | - |
| 16,319 | 4,737 | 1,322 | 369.78 | 507.29 | 596.19 | |
Revenue Growth (YoY) | 488.79% | 258.30% | 257.54% | -27.11% | -14.91% | -13.94% |
Cost of Revenue | 12,947 | 2,928 | 1,114 | 301.37 | 323.79 | 256.86 |
Gross Profit | 3,372 | 1,809 | 208.41 | 68.41 | 183.49 | 339.33 |
Selling, General & Admin | 5,446 | 3,326 | 2,662 | 3,037 | 3,092 | 2,637 |
Research & Development | 1,779 | 1,663 | 1,235 | 1,338 | 1,423 | 1,239 |
Amortization of Goodwill & Intangibles | 237.21 | 74.27 | 68.48 | 72.34 | 71.7 | 63.77 |
Operating Expenses | 8,068 | 5,469 | 4,226 | 4,673 | 4,721 | 4,037 |
Operating Income | -4,696 | -3,661 | -4,017 | -4,605 | -4,538 | -3,697 |
Interest Expense | -1,182 | -261.34 | -730.77 | -874.14 | -564.67 | -55.49 |
Interest & Investment Income | 216.45 | 129.95 | 141.07 | 170.34 | 99.68 | 96.96 |
Earnings From Equity Investments | -0.46 | - | -2,988 | -67.31 | 217.1 | 265.21 |
Currency Exchange Gain (Loss) | 7.85 | 9.42 | -9.53 | -7.42 | 1.74 | -9.96 |
Other Non Operating Income (Expenses) | 1,976 | 50.15 | 2,860 | -567.49 | -234.68 | 2.75 |
EBT Excluding Unusual Items | -3,679 | -3,733 | -4,744 | -5,951 | -5,019 | -3,398 |
Gain (Loss) on Sale of Investments | 5.25 | - | - | - | 29.8 | - |
Gain (Loss) on Sale of Assets | 96.5 | 40.88 | -63.87 | 0.02 | -10.38 | 108.92 |
Asset Writedown | -81.49 | -37.83 | -215.19 | -33.34 | -14.21 | - |
Pretax Income | -3,659 | -3,729 | -5,023 | -5,984 | -5,013 | -3,289 |
Income Tax Expense | 0.68 | 0.68 | 2.08 | -12.42 | 26.54 | -252.8 |
Earnings From Continuing Operations | -3,660 | -3,730 | -5,026 | -5,972 | -5,040 | -3,036 |
Minority Interest in Earnings | 0.36 | - | -0.72 | 0.1 | 10.74 | -11.38 |
Net Income | -3,659 | -3,730 | -5,026 | -5,972 | -5,029 | -3,047 |
Net Income to Common | -3,659 | -3,730 | -5,026 | -5,972 | -5,029 | -3,047 |
Shares Outstanding (Basic) | 30 | 29 | 25 | 21 | 20 | 20 |
Shares Outstanding (Diluted) | 30 | 29 | 25 | 21 | 20 | 20 |
Shares Change (YoY) | 144.11% | 15.64% | 18.93% | 4.73% | - | 1.20% |
EPS (Basic) | -123.25 | -128.35 | -200.01 | -282.61 | -249.26 | -151.04 |
EPS (Diluted) | -123.25 | -128.35 | -200.01 | -282.61 | -249.26 | -151.04 |
Free Cash Flow | -9,182 | -6,545 | -5,194 | -4,445 | -10,326 | -4,690 |
Free Cash Flow Per Share | -309.27 | -225.23 | -206.67 | -210.34 | -511.79 | -232.45 |
Gross Margin | 20.66% | 38.18% | 15.76% | 18.50% | 36.17% | 56.92% |
Operating Margin | -28.78% | -77.28% | -303.85% | -1245.36% | -894.52% | -620.15% |
Profit Margin | -22.42% | -78.74% | -380.17% | -1614.99% | -991.39% | -511.16% |
Free Cash Flow Margin | -56.27% | -138.17% | -392.84% | -1201.95% | -2035.58% | -786.69% |
EBITDA | -2,195 | -2,529 | -3,217 | -3,849 | -3,865 | -3,155 |
EBITDA Margin | -13.45% | -53.39% | -243.31% | - | - | - |
D&A For EBITDA | 2,501 | 1,132 | 800.4 | 756.35 | 673.08 | 542.17 |
EBIT | -4,696 | -3,661 | -4,017 | -4,605 | -4,538 | -3,697 |
EBIT Margin | -28.78% | -77.28% | - | - | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.